Clinical Trials Browser

Phase 2 × Recruiting × vorolanib × Clear all

NCT07386158 2026-02-04

Pucotenlimab Combination With Vorolanib as Neoadjuvant Therapy for ccRCC

Phase 2 Recruiting

Carcinoma, Renal Cell